feed,title,long_url,short_url
Investors,Charles River Labs Plummets 17% On 'Bleaker' Expectations For 2024,https://www.investors.com/news/technology/charles-river-laboratories-stock-charles-river-laboratories-earnings-q2-2024/,https://da.gd/UbMFY
Investors,"Novo Nordisk Slumps On Second-Quarter Miss, Light Ozempic, Wegovy Sales",https://www.investors.com/news/technology/novo-nordisk-stock-novo-nordisk-earnings-q2-2024/,https://da.gd/XbVt
